Infinity Pharmaceuticals Inc to Discuss Clinical Data from MARIO-275 - Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Infinity Pharmaceuticals ASCO Genitourinary Cancers Symposium Call.
(Operator Instructions)
Please be advised that today's conference is being recorded. (Operator Instructions)
I would now hand the conference over to your host today, Jayne Kauffman. Please go ahead.
Good morning, everyone, and welcome to today's call where we will review data from MARIO-275, which was presented today during the ASCO Genitourinary Cancer Symposium, or ASCO GU.
Participants on today's call are Adelene Perkins, Chief Executive Officer; and Dr. Brian Schwartz, Consulting Chief Physician from Infinity Pharmaceuticals.
During this call, we may make forward-looking statements about our future expectations and plans, including clinical development objectives, the therapeutic potential of our product candidates, our strategic plans and financial projections. Our actual results may differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |